| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lebanon | 40 | 2021 | 557 | 3.78 | Why? |
| Environmental Exposure | 6 | 2019 | 1558 | 1.72 | Why? |
| Water Pipe Smoking | 4 | 2017 | 47 | 1.64 | Why? |
| Asthma | 9 | 2018 | 4383 | 1.39 | Why? |
| Pesticides | 2 | 2019 | 100 | 1.33 | Why? |
| Prenatal Exposure Delayed Effects | 4 | 2019 | 319 | 1.29 | Why? |
| Alcohol Drinking | 4 | 2019 | 1663 | 1.01 | Why? |
| Maternal Exposure | 2 | 2017 | 173 | 0.75 | Why? |
| Air Pollution, Indoor | 2 | 2018 | 816 | 0.75 | Why? |
| Social Conditions | 2 | 2018 | 196 | 0.74 | Why? |
| Detergents | 1 | 2019 | 107 | 0.73 | Why? |
| Linguistics | 1 | 2017 | 50 | 0.69 | Why? |
| Tobacco Products | 1 | 2021 | 245 | 0.67 | Why? |
| Systole | 1 | 2018 | 252 | 0.66 | Why? |
| Health Knowledge, Attitudes, Practice | 10 | 2021 | 8811 | 0.66 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.65 | Why? |
| Cigarette Smoking | 2 | 2017 | 337 | 0.63 | Why? |
| Polypharmacy | 1 | 2018 | 347 | 0.60 | Why? |
| Community Pharmacy Services | 2 | 2018 | 426 | 0.57 | Why? |
| Cross-Sectional Studies | 34 | 2021 | 53120 | 0.57 | Why? |
| Disability Evaluation | 1 | 2018 | 671 | 0.57 | Why? |
| Medication Therapy Management | 1 | 2018 | 312 | 0.55 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2017 | 323 | 0.52 | Why? |
| Asbestos | 3 | 2017 | 45 | 0.51 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.50 | Why? |
| Smoking | 4 | 2019 | 3358 | 0.49 | Why? |
| Silicon Dioxide | 3 | 2017 | 131 | 0.48 | Why? |
| Overweight | 2 | 2019 | 916 | 0.48 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.47 | Why? |
| Urticaria | 1 | 2017 | 472 | 0.44 | Why? |
| Pharmacists | 3 | 2018 | 1246 | 0.44 | Why? |
| Quality of Life | 4 | 2020 | 9820 | 0.43 | Why? |
| Rhinitis, Allergic | 1 | 2018 | 704 | 0.43 | Why? |
| Psychometrics | 1 | 2018 | 1269 | 0.42 | Why? |
| Air Pollutants | 2 | 2018 | 3110 | 0.41 | Why? |
| Dermatitis, Atopic | 1 | 2018 | 714 | 0.40 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.40 | Why? |
| Cognition | 1 | 2019 | 1394 | 0.39 | Why? |
| Surveys and Questionnaires | 16 | 2021 | 43792 | 0.37 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.37 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.36 | Why? |
| Fear | 2 | 2020 | 3607 | 0.36 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.35 | Why? |
| Translating | 2 | 2018 | 80 | 0.35 | Why? |
| Intention | 1 | 2017 | 1380 | 0.35 | Why? |
| Hyperglycemia | 1 | 2019 | 1363 | 0.34 | Why? |
| Disabled Persons | 1 | 2018 | 1152 | 0.34 | Why? |
| Medication Errors | 2 | 2018 | 107 | 0.34 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.33 | Why? |
| Depression | 4 | 2021 | 14116 | 0.33 | Why? |
| Parents | 2 | 2018 | 2758 | 0.31 | Why? |
| Stress, Psychological | 3 | 2021 | 10231 | 0.31 | Why? |
| Risk Assessment | 4 | 2019 | 25439 | 0.31 | Why? |
| Prevalence | 11 | 2020 | 25773 | 0.30 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.29 | Why? |
| Socioeconomic Factors | 7 | 2020 | 8495 | 0.29 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.29 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.28 | Why? |
| Female | 49 | 2021 | 380317 | 0.28 | Why? |
| Male | 49 | 2021 | 367725 | 0.28 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.28 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.27 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3832 | 0.27 | Why? |
| Risk Factors | 18 | 2020 | 71621 | 0.27 | Why? |
| Nutrition Assessment | 2 | 2018 | 527 | 0.26 | Why? |
| Case-Control Studies | 7 | 2018 | 17671 | 0.26 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.24 | Why? |
| Adult | 35 | 2021 | 244371 | 0.24 | Why? |
| Stroke | 4 | 2019 | 8839 | 0.24 | Why? |
| Universities | 1 | 2017 | 4374 | 0.23 | Why? |
| Exercise | 3 | 2019 | 6771 | 0.22 | Why? |
| Dietary Approaches To Stop Hypertension | 1 | 2019 | 8 | 0.21 | Why? |
| Humans | 56 | 2021 | 930598 | 0.21 | Why? |
| Child, Preschool | 7 | 2019 | 36283 | 0.20 | Why? |
| Phobia, Social | 1 | 2019 | 30 | 0.20 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2020 | 6166 | 0.20 | Why? |
| Infant Welfare | 1 | 2019 | 17 | 0.20 | Why? |
| Middle Aged | 32 | 2019 | 270681 | 0.19 | Why? |
| Metal Ceramic Alloys | 1 | 2018 | 1 | 0.19 | Why? |
| Zirconium | 1 | 2018 | 10 | 0.19 | Why? |
| Chromium Alloys | 1 | 2018 | 10 | 0.19 | Why? |
| Air Pollution | 1 | 2018 | 3504 | 0.19 | Why? |
| Dental Bonding | 1 | 2018 | 10 | 0.19 | Why? |
| Alcohol-Related Disorders | 1 | 2019 | 84 | 0.19 | Why? |
| Chromium | 1 | 2018 | 27 | 0.19 | Why? |
| Marriage | 1 | 2019 | 83 | 0.19 | Why? |
| Africa, Northern | 1 | 2020 | 539 | 0.19 | Why? |
| Pregnancy | 5 | 2019 | 23879 | 0.18 | Why? |
| Students | 1 | 2017 | 5255 | 0.18 | Why? |
| Arab World | 1 | 2018 | 31 | 0.18 | Why? |
| Drug Utilization Review | 1 | 2019 | 72 | 0.18 | Why? |
| Nickel | 1 | 2018 | 55 | 0.18 | Why? |
| Nuts | 1 | 2017 | 22 | 0.18 | Why? |
| Meat Products | 1 | 2017 | 39 | 0.18 | Why? |
| Dairy Products | 1 | 2017 | 32 | 0.18 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.18 | Why? |
| Paternal Exposure | 1 | 2017 | 13 | 0.17 | Why? |
| Blood Coagulation Disorders, Inherited | 1 | 2018 | 82 | 0.17 | Why? |
| Anxiety | 2 | 2020 | 17311 | 0.17 | Why? |
| Infant Health | 1 | 2019 | 160 | 0.17 | Why? |
| Pharmacovigilance | 2 | 2018 | 501 | 0.17 | Why? |
| Child | 7 | 2019 | 70012 | 0.16 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.16 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 129 | 0.16 | Why? |
| Infant Care | 1 | 2019 | 178 | 0.15 | Why? |
| Lung Neoplasms | 3 | 2017 | 3228 | 0.15 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.15 | Why? |
| Efficiency | 1 | 2019 | 420 | 0.15 | Why? |
| Vancomycin | 1 | 2019 | 328 | 0.15 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.15 | Why? |
| Aged | 20 | 2019 | 215776 | 0.15 | Why? |
| Young Adult | 14 | 2021 | 93724 | 0.15 | Why? |
| Self Report | 2 | 2018 | 3802 | 0.15 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.15 | Why? |
| Middle East | 1 | 2020 | 1418 | 0.15 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.15 | Why? |
| Self Medication | 1 | 2017 | 131 | 0.15 | Why? |
| Logistic Models | 3 | 2019 | 9089 | 0.15 | Why? |
| Blood Glucose | 2 | 2020 | 3642 | 0.15 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.14 | Why? |
| Fasting | 1 | 2020 | 555 | 0.14 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.14 | Why? |
| Self Concept | 1 | 2019 | 490 | 0.14 | Why? |
| Mental Health | 2 | 2021 | 15770 | 0.14 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.14 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.14 | Why? |
| Occupational Exposure | 3 | 2017 | 4742 | 0.14 | Why? |
| Vehicle Emissions | 1 | 2017 | 328 | 0.14 | Why? |
| Arabs | 1 | 2017 | 298 | 0.14 | Why? |
| Awareness | 1 | 2018 | 529 | 0.13 | Why? |
| Vascular Stiffness | 1 | 2017 | 264 | 0.13 | Why? |
| Diet, Mediterranean | 1 | 2018 | 351 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.13 | Why? |
| Diabetic Nephropathies | 1 | 2017 | 315 | 0.13 | Why? |
| Tobacco Smoking | 1 | 2017 | 349 | 0.12 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.12 | Why? |
| Language | 1 | 2018 | 655 | 0.12 | Why? |
| Renal Dialysis | 3 | 2018 | 4358 | 0.12 | Why? |
| Independent Living | 1 | 2018 | 842 | 0.12 | Why? |
| Clinical Clerkship | 1 | 2018 | 403 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2019 | 88759 | 0.11 | Why? |
| Hospitals, General | 1 | 2017 | 711 | 0.11 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.11 | Why? |
| Kidney Failure, Chronic | 2 | 2018 | 3222 | 0.11 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.11 | Why? |
| Enoxaparin | 1 | 2018 | 1064 | 0.11 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.11 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.11 | Why? |
| Patient Education as Topic | 2 | 2018 | 1476 | 0.11 | Why? |
| Glycated Hemoglobin A | 1 | 2019 | 1316 | 0.11 | Why? |
| Nurse's Role | 1 | 2019 | 614 | 0.10 | Why? |
| Pharmacy Service, Hospital | 1 | 2018 | 645 | 0.10 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.10 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 1261 | 0.10 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| Suicidal Ideation | 1 | 2019 | 1226 | 0.10 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.10 | Why? |
| Patient-Centered Care | 1 | 2018 | 860 | 0.10 | Why? |
| Health Behavior | 2 | 2018 | 4449 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.10 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.10 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.09 | Why? |
| Trust | 1 | 2019 | 1487 | 0.09 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.09 | Why? |
| Guideline Adherence | 2 | 2019 | 2309 | 0.09 | Why? |
| Professional Role | 1 | 2018 | 1280 | 0.09 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.09 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 1165 | 0.09 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.09 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.09 | Why? |
| Sampling Studies | 2 | 2019 | 386 | 0.09 | Why? |
| Vascular Diseases | 1 | 2017 | 846 | 0.09 | Why? |
| Breast Feeding | 1 | 2019 | 1585 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Developing Countries | 2 | 2020 | 4283 | 0.08 | Why? |
| Physician-Patient Relations | 1 | 2017 | 1266 | 0.08 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.08 | Why? |
| Tuberculosis, Pulmonary | 1 | 2017 | 1171 | 0.08 | Why? |
| Factor Analysis, Statistical | 2 | 2018 | 538 | 0.08 | Why? |
| Retrospective Studies | 10 | 2019 | 105322 | 0.08 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.08 | Why? |
| Thrombophilia | 1 | 2018 | 1935 | 0.08 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Hypoglycemic Agents | 1 | 2019 | 2165 | 0.08 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.07 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.07 | Why? |
| Occupational Diseases | 2 | 2017 | 2787 | 0.07 | Why? |
| Education, Medical, Undergraduate | 1 | 2018 | 1392 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.07 | Why? |
| Multivariate Analysis | 3 | 2019 | 5440 | 0.07 | Why? |
| Tertiary Care Centers | 2 | 2019 | 8248 | 0.07 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Attitude of Health Personnel | 2 | 2018 | 4741 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Linear Models | 2 | 2019 | 1914 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Creatinine | 2 | 2019 | 1443 | 0.06 | Why? |
| Odds Ratio | 3 | 2019 | 5861 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.06 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.05 | Why? |
| Education, Pharmacy, Continuing | 1 | 2018 | 20 | 0.05 | Why? |
| Dental Stress Analysis | 1 | 2018 | 7 | 0.05 | Why? |
| Dental Porcelain | 1 | 2018 | 11 | 0.05 | Why? |
| Shear Strength | 1 | 2018 | 17 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.05 | Why? |
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 75 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.04 | Why? |
| Students, Medical | 1 | 2018 | 4032 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Computer-Aided Design | 1 | 2018 | 94 | 0.04 | Why? |
| Bronchial Provocation Tests | 1 | 2017 | 20 | 0.04 | Why? |
| Mental Disorders | 1 | 2021 | 6742 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Ethambutol | 1 | 2017 | 34 | 0.04 | Why? |
| France | 3 | 2019 | 12074 | 0.04 | Why? |
| Pyrazinamide | 1 | 2017 | 38 | 0.04 | Why? |
| Hospitalization | 2 | 2019 | 54280 | 0.04 | Why? |
| Mother-Child Relations | 1 | 2019 | 148 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Translations | 1 | 2017 | 153 | 0.04 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.04 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.04 | Why? |
| Tablets | 1 | 2017 | 219 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.04 | Why? |
| Work | 1 | 2019 | 342 | 0.04 | Why? |
| Soft Tissue Infections | 1 | 2017 | 116 | 0.04 | Why? |
| Quebec | 1 | 2017 | 498 | 0.04 | Why? |
| Mutation Rate | 1 | 2018 | 382 | 0.04 | Why? |
| Materials Testing | 1 | 2018 | 380 | 0.04 | Why? |
| Models, Psychological | 1 | 2019 | 383 | 0.04 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.03 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.03 | Why? |
| Risk | 2 | 2017 | 5288 | 0.03 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2021 | 1340 | 0.03 | Why? |
| Qatar | 1 | 2017 | 784 | 0.03 | Why? |
| Obsessive-Compulsive Disorder | 1 | 2021 | 486 | 0.03 | Why? |
| Immunoglobulin E | 1 | 2017 | 557 | 0.03 | Why? |
| Professional Practice | 1 | 2017 | 322 | 0.03 | Why? |
| Drug Resistance, Microbial | 1 | 2017 | 419 | 0.03 | Why? |
| Body Weight | 1 | 2019 | 1074 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Pharmacies | 1 | 2017 | 356 | 0.03 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.03 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 694 | 0.03 | Why? |
| Bias | 1 | 2018 | 1109 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.03 | Why? |
| Attitude | 1 | 2021 | 1481 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2019 | 926 | 0.03 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.03 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.03 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.03 | Why? |
| Schools, Medical | 1 | 2018 | 793 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2019 | 1530 | 0.03 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.02 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Diet | 1 | 2019 | 2052 | 0.02 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2019 | 1757 | 0.02 | Why? |
| Life Style | 1 | 2019 | 2708 | 0.02 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Health Promotion | 1 | 2019 | 2020 | 0.02 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Cities | 1 | 2017 | 4937 | 0.02 | Why? |
| Canada | 1 | 2017 | 6018 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Practice Guidelines as Topic | 2 | 2019 | 15421 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |